Selected research
Industry Research
Fc Fusion Protein for Autoimmune Disease Industry Research Report 2026
Market perspective
The global Fc Fusion Protein for Autoimmune Disease market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Fc Fusion Protein for Autoimmune Disease market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Fc Fusion Protein for Autoimmune Disease market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Fc Fusion Protein for Autoimmune Disease market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Fc Fusion Protein for Autoimmune Disease include Pfizer, Amgen, Celgen Biopharma, Bristol-Myers Squibb and 3SBIO, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Fc Fusion Protein for Autoimmune Disease market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Fc Fusion Protein for Autoimmune Disease.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Fc Fusion Protein for Autoimmune Disease Market by Company
Pfizer
Amgen
Celgen Biopharma
Bristol-Myers Squibb
3SBIO
Fc Fusion Protein for Autoimmune Disease Segment by Type
Orencia
Enbrel
Fc Fusion Protein for Autoimmune Disease Segment by Application
Rheumatoid Arthritis
Ankylosing Spondylitis
Psoriatic Arthritis
Juvenile Idiopathic Arthritis
Other
Fc Fusion Protein for Autoimmune Disease Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fc Fusion Protein for Autoimmune Disease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fc Fusion Protein for Autoimmune Disease and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fc Fusion Protein for Autoimmune Disease.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Fc Fusion Protein for Autoimmune Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Orencia
- Enbrel
Applications
- Rheumatoid Arthritis
- Ankylosing Spondylitis
- Psoriatic Arthritis
- Juvenile Idiopathic Arthritis
- Other
Companies covered
- Pfizer
- Amgen
- Celgen Biopharma
- Bristol-Myers Squibb
- 3SBIO
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Fc Fusion Protein for Autoimmune Disease by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Orencia
- 2.2.3 Enbrel
- 2.3 Fc Fusion Protein for Autoimmune Disease by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Rheumatoid Arthritis
- 2.3.3 Ankylosing Spondylitis
- 2.3.4 Psoriatic Arthritis
- 2.3.5 Juvenile Idiopathic Arthritis
- 2.3.6 Other
- 2.4 Assumptions and Limitations
3 Fc Fusion Protein for Autoimmune Disease Breakdown Data by Type
- 3.1 Global Fc Fusion Protein for Autoimmune Disease Historic Market Size by Type (2021-2026)
- 3.2 Global Fc Fusion Protein for Autoimmune Disease Forecasted Market Size by Type (2027-2032)
4 Fc Fusion Protein for Autoimmune Disease Breakdown Data by Application
- 4.1 Global Fc Fusion Protein for Autoimmune Disease Historic Market Size by Application (2021-2026)
- 4.2 Global Fc Fusion Protein for Autoimmune Disease Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Fc Fusion Protein for Autoimmune Disease Market Perspective (2021-2032)
- 5.2 Global Fc Fusion Protein for Autoimmune Disease Growth Trends by Region
- 5.2.1 Global Fc Fusion Protein for Autoimmune Disease Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Fc Fusion Protein for Autoimmune Disease Historic Market Size by Region (2021-2026)
- 5.2.3 Fc Fusion Protein for Autoimmune Disease Forecasted Market Size by Region (2027-2032)
- 5.3 Fc Fusion Protein for Autoimmune Disease Market Dynamics
- 5.3.1 Fc Fusion Protein for Autoimmune Disease Industry Trends
- 5.3.2 Fc Fusion Protein for Autoimmune Disease Market Drivers
- 5.3.3 Fc Fusion Protein for Autoimmune Disease Market Challenges
- 5.3.4 Fc Fusion Protein for Autoimmune Disease Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Fc Fusion Protein for Autoimmune Disease Players by Revenue
- 6.1.1 Global Top Fc Fusion Protein for Autoimmune Disease Players by Revenue (2021-2026)
- 6.1.2 Global Fc Fusion Protein for Autoimmune Disease Revenue Market Share by Players (2021-2026)
- 6.2 Global Fc Fusion Protein for Autoimmune Disease Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Fc Fusion Protein for Autoimmune Disease Head Office and Area Served
- 6.4 Global Fc Fusion Protein for Autoimmune Disease Players, Product Type & Application
- 6.5 Global Fc Fusion Protein for Autoimmune Disease Manufacturers Established Date
- 6.6 Global Fc Fusion Protein for Autoimmune Disease Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Fc Fusion Protein for Autoimmune Disease Market Size (2021-2032)
- 7.2 North America Fc Fusion Protein for Autoimmune Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Fc Fusion Protein for Autoimmune Disease Market Size by Country (2021-2026)
- 7.4 North America Fc Fusion Protein for Autoimmune Disease Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Fc Fusion Protein for Autoimmune Disease Market Size (2021-2032)
- 8.2 Europe Fc Fusion Protein for Autoimmune Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Fc Fusion Protein for Autoimmune Disease Market Size by Country (2021-2026)
- 8.4 Europe Fc Fusion Protein for Autoimmune Disease Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Market Size (2021-2032)
- 9.2 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Fc Fusion Protein for Autoimmune Disease Market Size (2021-2032)
- 10.2 South America Fc Fusion Protein for Autoimmune Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Fc Fusion Protein for Autoimmune Disease Market Size by Country (2021-2026)
- 10.4 South America Fc Fusion Protein for Autoimmune Disease Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Fc Fusion Protein for Autoimmune Disease Market Size (2021-2032)
- 11.2 Middle East & Africa Fc Fusion Protein for Autoimmune Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Fc Fusion Protein for Autoimmune Disease Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Fc Fusion Protein for Autoimmune Disease Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Pfizer
- 12.1.1 Pfizer Company Information
- 12.1.2 Pfizer Business Overview
- 12.1.3 Pfizer Revenue in Fc Fusion Protein for Autoimmune Disease Business (2021-2026)
- 12.1.4 Pfizer Fc Fusion Protein for Autoimmune Disease Product Portfolio
- 12.1.5 Pfizer Recent Developments
- 12.2 Amgen
- 12.2.1 Amgen Company Information
- 12.2.2 Amgen Business Overview
- 12.2.3 Amgen Revenue in Fc Fusion Protein for Autoimmune Disease Business (2021-2026)
- 12.2.4 Amgen Fc Fusion Protein for Autoimmune Disease Product Portfolio
- 12.2.5 Amgen Recent Developments
- 12.3 Celgen Biopharma
- 12.3.1 Celgen Biopharma Company Information
- 12.3.2 Celgen Biopharma Business Overview
- 12.3.3 Celgen Biopharma Revenue in Fc Fusion Protein for Autoimmune Disease Business (2021-2026)
- 12.3.4 Celgen Biopharma Fc Fusion Protein for Autoimmune Disease Product Portfolio
- 12.3.5 Celgen Biopharma Recent Developments
- 12.4 Bristol-Myers Squibb
- 12.4.1 Bristol-Myers Squibb Company Information
- 12.4.2 Bristol-Myers Squibb Business Overview
- 12.4.3 Bristol-Myers Squibb Revenue in Fc Fusion Protein for Autoimmune Disease Business (2021-2026)
- 12.4.4 Bristol-Myers Squibb Fc Fusion Protein for Autoimmune Disease Product Portfolio
- 12.4.5 Bristol-Myers Squibb Recent Developments
- 12.5 3SBIO
- 12.5.1 3SBIO Company Information
- 12.5.2 3SBIO Business Overview
- 12.5.3 3SBIO Revenue in Fc Fusion Protein for Autoimmune Disease Business (2021-2026)
- 12.5.4 3SBIO Fc Fusion Protein for Autoimmune Disease Product Portfolio
- 12.5.5 3SBIO Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst